Discover Research Beta
Browse peer-reviewed articles from Medwin Publishers' open access journals.
Showing 1–2 of 2 articles
"Umefune R"
×
Three Cases of Nasal and Oral Mucosal Melanoma Showing Pseudo-Progression after Immune Check Point Inhibitor Treatment
Mucosal melanoma is rare, comprising fewer than 2% of all cases of melanoma. Its prognosis is poor, with the five-year survival rate being lower than in patients with cutaneous or…
Mucosal melanoma
Pseudo-progression
Seronegative rheumatic irAE
Fatal Hepatitis Associated with Nivolumab and Ipilimumab Combination Therapy in the Patient with Malignant Melanoma
Immune checkpoint inhibitors are a common treatment for various malignancies, but these therapies are associated with several, immune-related adverse events. We report herein a ca…
Immune-related adverse event
Malignant melanoma
Combination therapy